Other candidate biomarkers have been studied as predictors of increased risk of COPD exacerbations [3, 9–11], including bone morphogenic protein-3, Cerberus 1, inhibin B, thrombopoietin, matrix metalloproteinase-10 and a number of interleukin family members [11]. The gene discussed is MMP10; the disease is chronic obstructive pulmonary disease.